287 related articles for article (PubMed ID: 19295284)
1. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
[TBL] [Abstract][Full Text] [Related]
2. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
3. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
Jeyakumar A; Cabeza R; Hindenburg A
Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
[TBL] [Abstract][Full Text] [Related]
4. Ovarian dysgerminoma with massive metastases to para-aortic lymph nodes.
Takemori M; Ichimura T; Nishimura R; Hasegawa K
Gynecol Obstet Invest; 2000; 49(3):211-3. PubMed ID: 10729765
[TBL] [Abstract][Full Text] [Related]
5. [Paclitaxel + carboplatin (TC)-resistant stage Ic squamous cell carcinomas arising in mature cystic teratomas of the ovary].
Ishikawa M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2010 Apr; 37(4):747-52. PubMed ID: 20414041
[TBL] [Abstract][Full Text] [Related]
6. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy in dysgerminoma].
Fechtig A; de Dycker RP; Schumacher T; Neumann RL
Geburtshilfe Frauenheilkd; 1991 May; 51(5):398-400. PubMed ID: 1869011
[TBL] [Abstract][Full Text] [Related]
8. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
Newton C; Murali K; Ahmad A; Hockings H; Graham R; Liberale V; Sarker SJ; Ledermann J; Berney DM; Shamash J; Banerjee S; Stoneham S; Lockley M
Eur J Cancer; 2019 May; 113():19-27. PubMed ID: 30954883
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
10. Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma.
Hino M; Kobayashi Y; Wada M; Hattori Y; Kurahasi T; Nakagawa H
J Obstet Gynaecol Res; 2016 Nov; 42(11):1613-1617. PubMed ID: 27785897
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Hatch KD; Homesley HD
J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
[TBL] [Abstract][Full Text] [Related]
13. PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative Group.
Pawinski A; Favalli G; Ploch E; Sahmoud T; van Oosterom AT; Pecorelli S
Clin Oncol (R Coll Radiol); 1998; 10(5):301-5. PubMed ID: 9848330
[TBL] [Abstract][Full Text] [Related]
14. Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary.
Kasenda B; Harter P; Hirsch T; Ast A; Buhrmann C; Glaser F; Du Bois A
Acta Obstet Gynecol Scand; 2009; 88(11):1288-90. PubMed ID: 19900144
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
17. Ovarian dysgerminoma associated with fibrosarcoma: a case report.
Alvarado-Cabrero I; Valencia-Cedillo R; Mohs-Alfaro M; De Anda-González J
Int J Gynecol Pathol; 2011 Sep; 30(5):466-9. PubMed ID: 21804387
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of ovarian germ cell tumors.
Williams SD
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943
[TBL] [Abstract][Full Text] [Related]
20. Recent management of malignant ovarian germ cell tumors: a study of 34 cases.
Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S
J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]